eISSN: 2299-0038
ISSN: 1643-8876
Menopause Review/Przegląd Menopauzalny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank


Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

without publication fees
1/2022
vol. 21
 
Share:
Send email
Share:
abstract:
Case report

A rare case of invasive micropapillary carcinoma of the breast

Georgios-Ioannis Verras
1
,
Francesk Mulita
1
,
Levan Tchabashvili
1
,
Ioanna-Maria Grypari
2
,
Sofia Sourouni
3
,
Evangelia Panagodimou
4
,
Maria-Ioanna Argentou
1

  1. Department of Surgery, Breast Unit, General University Hospital of Patras, Greece
  2. Pathology Department, University Hospital of Patras, Greece
  3. Department of Radiology, University Hospital of Patras, Greece
  4. Department of Gynecology and Obstetrics, University Hospital of Patras, Greece
Menopause Rev 2022; 21(1): 73-80
DOI: https://doi.org/10.5114/pm.2022.113834
Online publish date: 2022/02/21
View full text Get citation
 
PlumX metrics:
Invasive micropapillary carcinoma (IMPC) is a rare, distinct histological subtype of breast carcinoma. While micropapillary histological architecture is found in up to 2–8% of all breast cancers, pure micropapillary carcinoma is infrequent and comprises 0.9–2% of breast carcinomas. Invasive micropapillary carcinoma is emerging as an oncological and surgical challenge due to a plethora of characteristics that constitute this histological pattern – interestingly, both elusive and aggressive. We present the case of a woman presenting with IMPC, who was primarily treated with tumour and lymph node marking, followed by primary systemic therapy (PST), and consequent oncoplastic surgery with sentinel lymph node biopsy. Our case report outlines the importance of awareness of histological subtypes in breast cancer by focusing on a case report of IMPC. The breast surgeon must be aware of the lymphotropic behaviour of this subtype and the high prevalence of lymph node involvement in such patients, and therefore focus on rigorous axillary assessment. One must not forget that, despite having a more aggressive biological profile, IMPC has demonstrated no difference in survival when compared to other histological subtypes, and treatment should conform to international guidelines with an emphasis on nodal staging.
keywords:

breast, carcinoma, invasive, micropapillary
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.